Last $2.10 USD
Change Today -0.04 / -1.87%
Volume 35.3K
GNVC On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 5:20 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin M. Rooney

Former Director and Member of Audit Committee, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

48$41,299

Background*

Mr. Kevin M. Rooney has been the President of Beacon Consulting Group since 2007. Mr. Rooney served as Vice President of Oncology Sales and Marketing at Medimmune Inc. since July 2005. In this position, Mr. Rooney was responsible for strategic oversight of the sales and marketing organization for MedImmune's marketed oncology product, Ethyol. Mr. Rooney served as MedImmune's Senior Director of Marketing at Synagis until July 2005. Prior to MedImmune in July 2003, Mr. ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

2008-2013
Former Director and Member of Audit Committee

Education*

Bachelor's Degree
University of Virginia
Master's Degree
Northwestern University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options23,000
Total Number of Options23,000

Total Compensation*

Total Annual Cash Compensation$41,299
Total Calculated Compensation$41,299
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.10 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.